Immune Competence After Alemtuzumab Treatment of Multiple Sclerosis
Neurology - United States
doi 10.1212/wnl.0b013e3182a35215
Full Text
Open PDFAbstract
Available in full text
Categories
Date
August 7, 2013
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)